Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-08-31 · accession 0001493152-23-031708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-09-05 | 2023-08-31 | IMMX | Marquet Magda | Dir | P - Purchase | $2.01 | +1,000 | 1,000 | New | +$2,010 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-31 | P | A | 1,000 | $2.01 | 1,000 | I Via ALMA Life Sciences, LLC | — | — |